Barings LLC Biomarin Pharmaceutical Inc Transaction History

Barings LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$80.14 - $106.07 $168,614 - $223,171	-2,104 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$93.92 - $105.72 $163,045 - $183,529	-1,736 Reduced 45.21%	2,104 $204,000
Q4 2017 Feb 08, 2018	SELL	$80.76 - $95.13 $111,610 - $131,469	-1,382 Reduced 26.46%	3,840 $343,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,222	5,222 $0

621

182M

1.73M

1.73M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.7B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.